Digital Transformation in Pharma Manufacturing | David Holt, FactoryTalk | ISPE 2026 | Pharma Focus Asia
David Holt
Group Executive Director, FactoryTalk
David Holt is the Group Managing Director at Factory Talk, with extensive leadership experience across multiple industries. He focuses on innovative software solutions that enable the digital transformation of operations within GxP, pharmaceutical, and medical device-regulated industries.
AI Meets Composable MES: The Future of Pharma’s Digital Factory
At ISPE Singapore, our Pharma Focus Asia team met with David Holt, Group Executive Director at FactoryTalk, to discuss the evolving digital manufacturing landscape in life sciences.
From composable MES and AI adoption to validation and technology integration, Holt shares his perspective on how pharmaceutical manufacturers can build more flexible, scalable and connected digital operations.
Key Takeaways
- From point solutions to platforms: Pharmaceutical companies are increasingly looking to simplify fragmented technology environments and adopt platforms that can be standardised and scaled across sites.
- Composable MES is gaining momentum: A composable approach allows manufacturers to combine applications and capabilities around their specific operational requirements, rather than depending on one monolithic system.
- 38 no-code applications in one MES environment: Holt highlights an implementation involving approximately 38 no-code applications, integrated with systems including SAP, weighing scales and electronic logbooks.
- AI is moving towards practical applications: The focus is shifting from experimentation and proof-of-concepts towards controlled AI use cases that can deliver tangible value.
- AI can support experts rather than replace them: Holt describes AI as functioning like a “junior project member”, helping with tasks such as drafting while experienced professionals maintain oversight and accountability.
- Validation must keep pace with innovation: Traditional validation processes and procedures can create challenges when organisations are trying to introduce rapidly evolving technologies.
The Bigger Picture
The future of digital manufacturing in life sciences may not be defined by one technology alone. Instead, it will be shaped by how effectively manufacturers combine composable architectures, AI, connected systems and scalable platforms, while keeping people, processes and compliance at the centre.
Watch the full conversation with David Holt to explore the opportunities and challenges shaping the next generation of digital transformation in life sciences manufacturing.
Discover more insights and solutions from FactoryTalk.
